← DSP Mutual Fund

DSP Nifty Healthcare ETF

Index/ETF Data as of Oct 2026 Comparing Sep 2026 → Oct 2026
Share: WhatsApp X
Stocks Held
20
Oct 2026
Equity Holdings
₹17.57 Cr
Equity only, excl. debt & cash
Top 5 Weight
49.9%
High concentration
Top 10 Weight
76.3%
High concentration
Changes
20
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
81.8% of portfolio
Launch Date
11 Jan 2024
2 years old
📋 What Happened This Month Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 8.12% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 16.31%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 81.8%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Aug 2026 → Sep 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 80.7% 81.1% ▲ +0.4%
Healthcare Services 19.3% 18.8% ▼ -0.4%
Sep 2026 → Oct 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 81.1% 81.8% ▲ +0.7%
Healthcare Services 18.8% 18.2% ▼ -0.7%
↑
Biggest Add
Laurus Labs Limited
+1.31% · now 8.12%
↓
Biggest Trim
Sun Pharmaceutical Industries Limited
-0.68% · now 16.31%

What Changed in the Portfolio This Month?

Comparing Sep 2026 → Oct 2026

Sep 2026 → Oct 2026
↑ 7 Increased ↓ 13 Decreased
#StockSectorSep 2026Oct 2026Change
1
Laurus Labs Limited
₹1.43 Cr
Pharmaceuticals & Biotechnology 6.81% 8.12% +1.31%
2
Dr. Reddy's Laboratories Limited
₹1.26 Cr
Pharmaceuticals & Biotechnology 6.64% 7.15% +0.51%
3
Divi's Laboratories Limited
₹1.89 Cr
Pharmaceuticals & Biotechnology 10.43% 10.77% +0.34%
4
Zydus Lifesciences Limited
₹47.04 L
Pharmaceuticals & Biotechnology 2.54% 2.68% +0.14%
5
Apollo Hospitals Enterprise Limited
₹1.32 Cr
Healthcare Services 7.42% 7.53% +0.11%
6
Gland Pharma Limited
₹37.62 L
Pharmaceuticals & Biotechnology 2.04% 2.14% +0.10%
7
Cipla Limited
₹1.18 Cr
Pharmaceuticals & Biotechnology 6.69% 6.73% +0.04%
#StockSectorSep 2026Oct 2026Change
1
Sun Pharmaceutical Industries Limited
₹2.87 Cr
Pharmaceuticals & Biotechnology 16.99% 16.31% -0.68%
2
Max Healthcare Institute Limited
₹97.54 L
Healthcare Services 6.11% 5.55% -0.56%
3
Torrent Pharmaceuticals Limited
₹1.03 Cr
Pharmaceuticals & Biotechnology 6.24% 5.88% -0.36%
4
Biocon Limited
₹37.36 L
Pharmaceuticals & Biotechnology 2.28% 2.12% -0.16%
5
Krishna Institute Of Medical Sciences Limited
₹28.54 L
Healthcare Services 1.76% 1.62% -0.14%
6
Lupin Limited
₹74.45 L
Pharmaceuticals & Biotechnology 4.36% 4.23% -0.13%
7
Glenmark Pharmaceuticals Limited
₹52.76 L
Pharmaceuticals & Biotechnology 3.11% 3.00% -0.11%
8
Abbott India Limited
₹20.25 L
Pharmaceuticals & Biotechnology 1.26% 1.15% -0.11%
9
Alkem Laboratories Limited
₹46.99 L
Pharmaceuticals & Biotechnology 2.75% 2.67% -0.08%
10
Fortis Healthcare Limited
₹61.00 L
Healthcare Services 3.54% 3.47% -0.07%

What Stocks Does This Fund Hold?

20 stocks — Oct 2026

# Stock Sector Cap Weight & Value
1
₹2.87 Cr
Pharmaceuticals & Biotechnology
16.31%
2
₹1.89 Cr
Pharmaceuticals & Biotechnology
10.77%
3
₹1.43 Cr
Pharmaceuticals & Biotechnology
8.12%
4
₹1.32 Cr
Healthcare Services
7.53%
5
₹1.26 Cr
Pharmaceuticals & Biotechnology
7.15%
6
₹1.18 Cr
Pharmaceuticals & Biotechnology
6.73%
7
₹1.03 Cr
Pharmaceuticals & Biotechnology
5.88%
8
₹97.54 L
Healthcare Services
5.55%
9
₹74.45 L
Pharmaceuticals & Biotechnology
4.23%
10
₹70.82 L
Pharmaceuticals & Biotechnology
4.03%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 DSP Mutual Fund — Portfolio & Holdings
See all funds managed by DSP Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.